Literature DB >> 3171228

AIDS two months after primary human immunodeficiency virus infection.

B Isaksson1, J Albert, F Chiodi, A Furucrona, A Krook, P Putkonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3171228     DOI： 10.1093/infdis/158.4.866

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Pattern of gp120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection.

Authors:  W K Wang; M Essex; M F McLane; K H Mayer; C C Hsieh; H G Brumblay; G Seage; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 2.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10

3.  Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  L Zhang; Y Huang; H Yuan; B K Chen; J Ip; D D Ho
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection.

Authors:  S Shalekoff; C T Tiemessen; C M Gray; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Analysis of antibody responses to phenotypically distinct lentiviruses.

Authors:  O Kajikawa; M D Lairmore; J C DeMartini
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

6.  Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Authors:  Elena Priceputu; Zaher Hanna; Chunyan Hu; Marie-Chantal Simard; Patrick Vincent; Steffen Wildum; Michael Schindler; Frank Kirchhoff; Paul Jolicoeur
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

7.  Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.

Authors:  Judith Dalmau; Maria Carmen Puertas; Marta Azuara; Ana Mariño; Nicole Frahm; Beatriz Mothe; Nuria Izquierdo-Useros; Maria José Buzón; Roger Paredes; Lourdes Matas; Todd M Allen; Christian Brander; Carlos Rodrigo; Bonaventura Clotet; Javier Martinez-Picado
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

8.  Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments.

Authors:  R T Horvat; C Wood; S F Josephs; N Balachandran
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Thalidomide inhibits lipoarabinomannan-induced upregulation of human immunodeficiency virus expression.

Authors:  P K Peterson; G Gekker; M Bornemann; D Chatterjee; C C Chao
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 10.  Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention.

Authors:  H Atlan; M J Gersten; P L Salk; J Salk
Journal:  Res Immunol       Date:  1994 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.